A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
Recruiting · NCT05584670 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-06-23 | NCT05584670 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Christiana Care Health System - Newark- Site Number : 8400011 | Newark | United States | 1 |
| Fred Hutchinson Cancer Center- Site Number : 8400010 | Seattle | United States | 1 |
| John Theurer Cancer Center- Site Number : 8400001 | Hackensack | United States | 1 |
| Karmanos Cancer Institute - Detroit- Site Number : 8400006 | Detroit | United States | 1 |
| NYU Langone Medical Center- Site Number : 8400013 | New York | United States | 1 |
| Rhode Island Hospital - Providence - Eddy Street- Site Number : 8400004 | Providence | United States | 1 |
| The University of Kansas Cancer Center - Westwood- Site Number : 8400008 | Westwood | United States | 1 |
| The University of Texas MD Anderson Cancer Center- Site Number : 8400005 | Houston | United States | 1 |
| University of Iowa- Site Number : 8400014 | Iowa City | United States | 1 |